Last updated on February 2020

A Study of Apalutamide in Participants With High Risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy


Brief description of study

The purpose of this study is to determine if treatment with androgen deprivation therapy (ADT) plus apalutamide before and after radical prostatectomy in participants with high-risk localized or locally advanced prostate cancer results in an improvement in pathological complete response (pCR) rate and metastasis-free survival (MFS), as compared to ADT plus placebo.

Detailed Study Description

High-risk prostate cancer accounts for approximately 15 percent (%) of newly diagnosed prostate cancers. A systemic therapy that eradicates micrometastatic disease is needed to improve survival in high-risk participants undergoing radical prostatectomy. It is hypothesized that androgen blockade prior to and after radical prostatectomy may improve outcomes for participants at the highest risk for recurrence. This study is designed to evaluate if androgen blockade administered prior to and after radical prostatectomy will increase the rate of pathological complete response (pCR) and lead to better overall outcomes. ERLEADA (apalutamide, also known as JNJ-56021927 and ARN-509) is an orally available, non-steroidal small molecule, which acts as a potent and selective antagonist of the androgen receptor (AR), currently being developed for the treatment of prostate cancer. The study includes screening phase (approximately up to 35 days before randomization), treatment phase (up to 12 months) and follow-up phase. The end of study (study completion) is defined as last participant assessment at study site with approximate study duration of 8 years. Participants will undergo efficacy, pharmacokinetics and biomarker evaluations. The safety will be monitored throughout the study.

Clinical Study Identifier: NCT03767244

Find a site near you

Start Over

University of Southern California

Los Angeles, CA United States
  Connect »

Cedars-Sinai Medical Center

Los Angeles, CA United States
  Connect »

UC Davis Medical Center

Sacramento, CA United States
  Connect »

Stamford Hospital

Stamford, CT United States
  Connect »

Urology Specialists LLC

Hialeah, FL United States
  Connect »

University of Florida

Jacksonville, FL United States
  Connect »

Florida Hospital

Orlando, FL United States
  Connect »

University of Chicago

Chicago, IL United States
  Connect »

DuPage Medical Group

Lisle, IL United States
  Connect »

Wichita Urology Group

Wichita, KS United States
  Connect »

Regional Urology

Shreveport, LA United States
  Connect »

Saint Louis University

Saint Louis, MO United States
  Connect »

Washington University

Saint Louis, MO United States
  Connect »

Garden State Urology

Morristown, NJ United States
  Connect »

Albany Medical College

Albany, NY United States
  Connect »

SUNY Upstate Med Univ

Syracuse, NY United States
  Connect »

University of North Carolina

Chapel Hill, NC United States
  Connect »

Alliance Urology Specialists

Greensboro, NC United States
  Connect »

Carolina Urology Partners, PLLC

Huntersville, NC United States
  Connect »

Cleveland VA Medical Center

Cleveland, OH United States
  Connect »

Oklahoma City VAMC

Oklahoma City, OK United States
  Connect »

Omega Medical Research

Warwick, RI United States
  Connect »

Greenville Health

Greenville, SC United States
  Connect »

Carolina Urologic Research Center

Myrtle Beach, SC United States
  Connect »

Virginia Urology

Richmond, VA United States
  Connect »

Urology of Virginia, PLCC

Virginia Beach, VA United States
  Connect »

Hospital Italiano de Buenos Aires

Ciudad Autonoma de, Argentina
  Connect »

Uroclinica

Mendoza, Argentina
  Connect »

Clinica Mayo de UMCB

San Miguel de Tucuman, Argentina
  Connect »

Austin Health

Heidelberg, Australia
  Connect »

Westmead Hospital

Westmead, Australia
  Connect »

Clinique de la Croix du Sud

Quint-Fonsegrives, France
  Connect »

Praxis Dr. med. Ralf Eckert

Lutherstadt Eisleben, Germany
  Connect »

Generale Regionale F. Miulli

Acquaviva delle Fonti, Italy
  Connect »

Chiba Cancer Center

Chuo-ku, Chiba-City,, Japan
  Connect »

Kitasato University Hospital

Minami-ku, Sagamihara-shi, Japan
  Connect »

Severance Hospital

Seoul, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Seoul St. Mary's Hospital

Seoul, Korea, Republic of
  Connect »

NKI-AVL, Amsterdam

Amsterdam, Netherlands
  Connect »

Catharinaziekenhuis

Eindhoven, Netherlands
  Connect »

Yale Cancer Center

New Haven, CT United States
  Connect »

University of Toledo

Toledo, OH United States
  Connect »

Penn State Health

Hershey, PA United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Texas Oncology

Plano, TX United States
  Connect »

Hosp. de Jerez de La Frontera

Jerez de la Frontera, Spain
  Connect »

Southmead Hospital

Bristol, United Kingdom
  Connect »

Ninewells Hospital

Dundee, United Kingdom
  Connect »

Southampton General Hospital

Southampton, United Kingdom
  Connect »

Royal Marsden Hospital

Sutton, United Kingdom
  Connect »

MidYorkshire NHS Trust

Wakefield, United Kingdom
  Connect »

New Cross Hospital

Wolverhampton, United Kingdom
  Connect »

Texas Oncology P.A.

Houston, TX United States
  Connect »

Kitasato University Hospital

Minami-Ku, Sagamihara-Shi, Japan
  Connect »